INO
Price
$1.33
Change
-$0.81 (-37.85%)
Updated
Jul 3, 02:00 PM (EDT)
Capitalization
78.48M
ONWRF
Price
$5.45
Change
+$0.21 (+4.01%)
Updated
Jul 2 closing price
Capitalization
236.27M
Interact to see
Advertisement

INO vs ONWRF

Header iconINO vs ONWRF Comparison
Open Charts INO vs ONWRFBanner chart's image
Inovio Pharmaceuticals
Price$1.33
Change-$0.81 (-37.85%)
Volume$663.73K
Capitalization78.48M
Onward Med
Price$5.45
Change+$0.21 (+4.01%)
Volume$1.86K
Capitalization236.27M
INO vs ONWRF Comparison Chart in %
Loading...
INO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ONWRF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
INO vs. ONWRF commentary
Jul 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is INO is a Hold and ONWRF is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 04, 2025
Stock price -- (INO: $2.14 vs. ONWRF: $5.45)
Brand notoriety: INO: Notable vs. ONWRF: Not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: INO: 168% vs. ONWRF: 166%
Market capitalization -- INO: $78.48M vs. ONWRF: $236.27M
INO [@Biotechnology] is valued at $78.48M. ONWRF’s [@Biotechnology] market capitalization is $236.27M. The market cap for tickers in the [@Biotechnology] industry ranges from $306.14B to $0. The average market capitalization across the [@Biotechnology] industry is $2.35B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

INO’s FA Score shows that 0 FA rating(s) are green whileONWRF’s FA Score has 0 green FA rating(s).

  • INO’s FA Score: 0 green, 5 red.
  • ONWRF’s FA Score: 0 green, 5 red.
According to our system of comparison, ONWRF is a better buy in the long-term than INO.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

INO’s TA Score shows that 6 TA indicator(s) are bullish while ONWRF’s TA Score has 5 bullish TA indicator(s).

  • INO’s TA Score: 6 bullish, 2 bearish.
  • ONWRF’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, INO is a better buy in the short-term than ONWRF.

Price Growth

INO (@Biotechnology) experienced а -3.17% price change this week, while ONWRF (@Biotechnology) price change was +19.81% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +7.15%. For the same industry, the average monthly price growth was +33.42%, and the average quarterly price growth was +4.05%.

Reported Earning Dates

INO is expected to report earnings on May 13, 2025.

Industries' Descriptions

@Biotechnology (+7.15% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ONWRF($236M) has a higher market cap than INO($78.5M). INO YTD gains are higher at: 20.225 vs. ONWRF (-9.147).
INOONWRFINO / ONWRF
Capitalization78.5M236M33%
EBITDA-93.37MN/A-
Gain YTD20.225-9.147-221%
P/E RatioN/AN/A-
Revenue283KN/A-
Total Cash68.4MN/A-
Total Debt11.3MN/A-
FUNDAMENTALS RATINGS
INO: Fundamental Ratings
INO
OUTLOOK RATING
1..100
6
VALUATION
overvalued / fair valued / undervalued
1..100
58
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
59
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
INOONWRF
RSI
ODDS (%)
N/A
Bearish Trend 2 days ago
71%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
60%
Momentum
ODDS (%)
Bullish Trend 2 days ago
74%
Bullish Trend 2 days ago
31%
MACD
ODDS (%)
Bullish Trend 2 days ago
77%
Bullish Trend 2 days ago
31%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
89%
Bullish Trend 2 days ago
32%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
76%
Bullish Trend 2 days ago
36%
Advances
ODDS (%)
Bullish Trend 2 days ago
77%
Bullish Trend 2 days ago
50%
Declines
ODDS (%)
Bearish Trend 4 days ago
88%
N/A
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
79%
Bearish Trend 2 days ago
50%
Aroon
ODDS (%)
Bullish Trend 2 days ago
69%
Bearish Trend 2 days ago
60%
View a ticker or compare two or three
Interact to see
Advertisement
INO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ONWRF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MPGFX173.06N/A
N/A
Mairs & Power Growth
ITGSX92.77N/A
N/A
VY® T. Rowe Price Growth Equity S
ICRPX25.85N/A
N/A
VY® CBRE Real Estate A
SIVIX16.90N/A
N/A
State Street Instl Small-Cap Equity Inv
GGLCX12.43N/A
N/A
Gabelli International Small Cap C

INO and

Correlation & Price change

A.I.dvisor indicates that over the last year, INO has been loosely correlated with RPTX. These tickers have moved in lockstep 58% of the time. This A.I.-generated data suggests there is some statistical probability that if INO jumps, then RPTX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To INO
1D Price
Change %
INO100%
+4.90%
RPTX - INO
58%
Loosely correlated
+1.41%
BCYC - INO
55%
Loosely correlated
+5.83%
AXON - INO
53%
Loosely correlated
-0.09%
ARRY - INO
52%
Loosely correlated
+4.82%
ONCO - INO
50%
Loosely correlated
+3.19%
More

ONWRF and

Correlation & Price change

A.I.dvisor indicates that over the last year, ONWRF has been loosely correlated with SHJBF. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if ONWRF jumps, then SHJBF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ONWRF
1D Price
Change %
ONWRF100%
+4.03%
SHJBF - ONWRF
42%
Loosely correlated
N/A
CNTA - ONWRF
24%
Poorly correlated
+4.33%
UCBJF - ONWRF
23%
Poorly correlated
N/A
INO - ONWRF
22%
Poorly correlated
+4.90%
RGLS - ONWRF
21%
Poorly correlated
N/A
More